KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Change in Acquisitions & Divestments: 2009-2025

Historic Change in Acquisitions & Divestments for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Sep 2025 value amounting to $3.4 billion.

  • Regeneron Pharmaceuticals' Change in Acquisitions & Divestments fell 20.98% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year decrease of 21.95%. This contributed to the annual value of $15.0 billion for FY2024, which is 59.15% up from last year.
  • Latest data reveals that Regeneron Pharmaceuticals reported Change in Acquisitions & Divestments of $3.4 billion as of Q3 2025, which was up 55.22% from $2.2 billion recorded in Q2 2025.
  • Regeneron Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $4.3 billion during Q3 2024, with a 5-year trough of $318.0 million in Q4 2021.
  • Over the past 3 years, Regeneron Pharmaceuticals' median Change in Acquisitions & Divestments value was $3.0 billion (recorded in 2023), while the average stood at $3.0 billion.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments crashed by 66.67% in 2021 and then skyrocketed by 383.46% in 2022.
  • Over the past 5 years, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $318.0 million in 2021, then spiked by 383.46% to $1.5 billion in 2022, then soared by 55.00% to $2.4 billion in 2023, then increased by 8.36% to $2.6 billion in 2024, then fell by 20.98% to $3.4 billion in 2025.
  • Its Change in Acquisitions & Divestments was $3.4 billion in Q3 2025, compared to $2.2 billion in Q2 2025 and $3.5 billion in Q1 2025.